AGC Biologics
About AGC Biologics
Categories
-
US
-
2018On CPHI since
-
1000 - 4999Employees
Company types
Primary activities
Meet us at
CPHI Americas 2025
Pennsylvania Convention Center, Philadelphia
20 May 2025 - 22 May 2025
AGC Biologics Resources (5)
-
News AGC Biologics to increase capacity for pDNA and mRNA manufacturing in Heidelberg
The expansion plans include an additional manufacturing line, a new cleanroom and a new process development lab -
News AGC Biologics and Rocket Pharma expand LVV manufacturing partnership
The expanded agreement will ensure Rocket Pharma's supply of lentiviral vectors across its pipeline -
News AGC Biologics becomes first manufacturer of newly approved Libmeldy
The CDMO will use its gene and cell therapy commercial expertise to bring "remarkable innovation" to young eligible patients -
News AGC Biologics to boost its biopharmaceutical CDMO capacity in Denmark
The €160 million investment will double the company's single-use bioreactor mammalian cell-culture capacity -
News AGC Biologics to complete acquisition of MolMed on 31 July
The transaction will enable the CDMO to offer plasmid production and end-to-end cell and gene therapy services.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance